Will Mydecine's Move Make the Market for Pharmaceutical Psilocybin Mushroom?
Psychedelic companies hoping to capitalize on a surging interest in psilocybin treatments have been limited to one source for research grade psilocybin. Until now.
Stock Picking Has Become Quite Difficult
The big question is how does this action resolve itself?
After Smoke Clears, Pot Industry Could See M&A Activity Light Up
Real Money tapped an industry expert to discuss the outlook for buying and selling of cannabis companies.
There's a Shift in the Action Tuesday
It requires some increased emphasis on defense just in case it develops into something more significant.
GrowGeneration Should Generate Higher Prices Ahead Based on Bullish Charts
Traders interested in the retailer of hydroponic equipment should wait for some sideways trading action before probing the long side.
Jim Cramer: Here's One Specialized Chain That's Growing Like a Weed
If the Democrats sweep, you have perhaps the best single stock in the market.
Market Is Choppy, Sloppy, and Mixed but With Green Shoots
Despite the bumps and bearish arguments, we still see some good stock picking.
Any Buys I'm Making at This Point Are Incremental
I'm growing increasingly cautious but I'm still finding some stock picks that are working.
2 of My Core Holdings Are on My Radar
While breadth is very good Wednesday, it isn't flowing into the speculative names.
Pot Cos. Find That High Isn't Good When It Comes to Cost
Value customers drive move away luxury pot products.